61566-33-4

Basic information

• Product Name: methyl 2-(4-isobutylphenyl)acetate
• Synonyms: Benzeneacetic acid, 4-(2-Methylpropyl)-, Methyl ester;methyl 2-(4-isobutylphenyl)acetate;p-isobutylphenylacetic acid methyl ester
• CAS NO: 61566-33-4
• Molecular Formula: C₁₃H₁₈O₂
• Molecular Weight: 206.28082
• Mol File: 61566-33-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 276.151°C at 760 mmHg
• Flash Point: 104.11°C
• Appearance: /
• Density: 0.99g/cm³
• Vapor Pressure: 0.005mmHg at 25°C
• Refractive Index: 1.497
• Storage Temp.: 2-8°C
• CAS DataBase Reference: methyl 2-(4-isobutylphenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(4-isobutylphenyl)acetate(61566-33-4)
• EPA Substance Registry System: methyl 2-(4-isobutylphenyl)acetate(61566-33-4)

Safety Data

• Hazardous Substances Data: 61566-33-4(Hazardous Substances Data)

Usage

Description

Methyl 2-(4-isobutylphenyl)acetate, also known as Ibufenac Methyl Ester, is a chemical compound derived from Ibufenac. It is characterized by its ester functional group and a unique molecular structure that includes an isobutyl group attached to a phenyl ring. methyl 2-(4-isobutylphenyl)acetate is known for its analgesic and anti-inflammatory properties.

Uses

Used in Pharmaceutical Industry:
Methyl 2-(4-isobutylphenyl)acetate is used as an analgesic and anti-inflammatory agent for the treatment of various pain and inflammation conditions. Its application in this industry is due to its ability to alleviate pain and reduce inflammation, making it a valuable component in the development of pharmaceutical products for pain management and treatment of inflammatory diseases.
Used in Research and Development:
In addition to its pharmaceutical applications, methyl 2-(4-isobutylphenyl)acetate is also utilized in research and development for the study of its chemical properties, potential interactions with other compounds, and its role in various biological processes. This research can lead to the discovery of new applications and improvements in existing pharmaceutical formulations.

InChI:InChI=1/C13H18O2/c1-10(2)8-11-4-6-12(7-5-11)9-13(14)15-3/h4-7,10H,8-9H2,1-3H3

Upstream product

• 38861-78-8 1-(4-isobutyl-phenyl)-ethanone 
• 149-73-5 trimethyl orthoformate 
• 67-56-1 methanol 
• 1553-60-2 ibufenac 
• 40150-98-9 4-(2-methyl-1-propyl)benzaldehyde 

Downstream Products

• 188650-93-3 1-((1R,5S,7S)-10,10-Dimethyl-3,3-dioxo-3λ⁶-thia-4-aza-tricyclo[5.2.1.0^1,5]dec-4-yl)-2-(4-isobutyl-phenyl)-ethanone 
• 61566-34-5 (+/-)-ibuprofen methyl ester 
• 674776-27-3 (+/-)-methyl 3-cyano-2-(4-isobutylphenyl)propionate 
• 674776-29-5 (+/-)-3-cyano-2-(4-isobutylphenyl)propionic acid 
• 674776-43-3 (S)-3-cyano-2-(4-isobutylphenyl)propionic acid 
• 674776-41-1 (R)-3-cyano-2-(4-isobutylphenyl)propionic acid 
• 674776-35-3 (3R)-4,4-dimethyl-2-oxo-1-phenylpyrrolidin-3-yl (2R)-3-cyano-2-(4-isobutylphenyl)propionate 
• 223406-35-7 (R)-2-[(S)-3-(4-Isobutyl-phenyl)-3-methyl-2-oxo-pyrrolidin-1-yl]-propionic acid methyl ester 
• 51146-56-6 (S)-ibuprofen 
• 188650-94-4 (S)-1-((1R,5S,7S)-10,10-Dimethyl-3,3-dioxo-3λ⁶-thia-4-aza-tricyclo[5.2.1.0^1,5]dec-4-yl)-2-(4-isobutyl-phenyl)-propan-1-one 
• 110319-74-9 N-hydroxy-N-methyl-3-methyl-2-<4-(2-methylpropyl)phenyl>butanamide 
• 110319-84-1 3-methyl-2-<4-(2-methylpropyl)phenyl>butanoic acid 
• 51631-62-0 2-(4-Isobutyl-phenyl)-3-methyl-butyryl chloride 
• 1228664-31-0 [11C]-ibuprofen methyl ester 

Relevant articles and documents

Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen

Inhibition of fatty acid amide hydrolase (FAAH) reduces the gastrointestinal damage produced by non-steroidal anti-inflammatory agents such as sulindac and indomethacin in experimental animals, suggesting that a dual-action FAAH-cyclooxygenase (COX) inhib

Ene reductase-catalysed synthesis of (R)-profen derivatives

Enantiomerically pure (R)-profen derivatives and intermediates are synthesised utilising the enzyme YqjM, an ene reductase from Bacillus subtilis. After optimisation of the reaction conditions, the chemoenzymatic approach was applied for the first time in the synthesis of (R)-flurbiprofen methyl ester. Copyright